These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31811202)

  • 1. Unravelling Receptor and RGD Motif Dependence of Retargeted Adenoviral Vectors using Advanced Tumor Model Systems.
    Chernyavska M; Schmid M; Freitag PC; Palacio-Castañeda V; Piruska A; Huck WTS; Plückthun A; Verdurmen WPR
    Sci Rep; 2019 Dec; 9(1):18568. PubMed ID: 31811202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of penton base Arg-Gly-Asp motifs with integrins is crucial for adenovirus serotype 35 vector transduction in human hematopoietic cells.
    Murakami S; Sakurai F; Kawabata K; Okada N; Fujita T; Yamamoto A; Hayakawa T; Mizuguchi H
    Gene Ther; 2007 Nov; 14(21):1525-33. PubMed ID: 17805302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fetal muscle gene transfer is not enhanced by an RGD capsid modification to high-capacity adenoviral vectors.
    Bilbao R; Reay DP; Hughes T; Biermann V; Volpers C; Goldberg L; Bergelson J; Kochanek S; Clemens PR
    Gene Ther; 2003 Oct; 10(21):1821-9. PubMed ID: 12960972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AdEasy-based cloning system to generate tropism expanded replicating adenoviruses expressing transgenes late in the viral life cycle.
    Lie-A-Ling M; Bakker CT; Wesseling JG; Bosma PJ
    Gene Ther; 2005 Sep; 12(17):1347-52. PubMed ID: 15877046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient and selective gene transfer into primary human brain tumors by using single-chain antibody-targeted adenoviral vectors with native tropism abolished.
    van Beusechem VW; Grill J; Mastenbroek DC; Wickham TJ; Roelvink PW; Haisma HJ; Lamfers ML; Dirven CM; Pinedo HM; Gerritsen WR
    J Virol; 2002 Mar; 76(6):2753-62. PubMed ID: 11861842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retargeted adenoviral cancer gene therapy for tumour cells overexpressing epidermal growth factor receptor or urokinase-type plasminogen activator receptor.
    Harvey TJ; Burdon D; Steele L; Ingram N; Hall GD; Selby PJ; Vile RG; Cooper PA; Shnyder SD; Chester JD
    Gene Ther; 2010 Aug; 17(8):1000-10. PubMed ID: 20410926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of fiber-modified adenovirus vectors containing heterologous peptides in both the HI loop and C terminus of the fiber knob.
    Koizumi N; Mizuguchi H; Utoguchi N; Watanabe Y; Hayakawa T
    J Gene Med; 2003 Apr; 5(4):267-76. PubMed ID: 12692861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy for esophageal carcinoma: the use of an explant model to test adenoviral vectors ex vivo.
    Marsman WA; Buskens CJ; Wesseling JG; Offerhaus GJ; Bergman JJ; Tytgat GN; van Lanschot JJ; Bosma PJ
    Cancer Gene Ther; 2004 Apr; 11(4):289-96. PubMed ID: 14765131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced transduction efficiency of fiber-substituted adenovirus vectors by the incorporation of RGD peptides in two distinct regions of the adenovirus serotype 35 fiber knob.
    Matsui H; Sakurai F; Katayama K; Kurachi S; Tashiro K; Sugio K; Kawabata K; Mizuguchi H
    Virus Res; 2011 Jan; 155(1):48-54. PubMed ID: 20801174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conditionally replication-competent adenoviral vectors with enhanced infectivity for use in gene therapy of melanoma.
    Liu Y; Ye T; Sun D; Maynard J; Deisseroth A
    Hum Gene Ther; 2004 Jul; 15(7):637-47. PubMed ID: 15242524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting EGFR with metabolically biotinylated fiber-mosaic adenovirus.
    Pereboeva L; Komarova S; Roth J; Ponnazhagan S; Curiel DT
    Gene Ther; 2007 Apr; 14(8):627-37. PubMed ID: 17251987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phylogenetic analysis and structural predictions of human adenovirus penton proteins as a basis for tissue-specific adenovirus vector design.
    Madisch I; Hofmayer S; Moritz C; Grintzalis A; Hainmueller J; Pring-Akerblom P; Heim A
    J Virol; 2007 Aug; 81(15):8270-81. PubMed ID: 17522221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helper-dependent adenoviral vectors containing modified fiber for improved transduction of developing and mature muscle cells.
    Bramson JL; Grinshtein N; Meulenbroek RA; Lunde J; Kottachchi D; Lorimer IA; Jasmin BJ; Parks RJ
    Hum Gene Ther; 2004 Feb; 15(2):179-88. PubMed ID: 14975190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast growth factor-2-retargeted adenoviral vector for selective transduction of primary glioblastoma multiforme endothelial cells.
    Gupta V; Wang W; Sosnowski BA; Hofman FM; Chen TC
    Neurosurg Focus; 2006 Apr; 20(4):E26. PubMed ID: 16709032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retargeted adenoviruses for radiation-guided gene delivery.
    Kaliberov SA; Kaliberova LN; Yan H; Kapoor V; Hallahan DE
    Cancer Gene Ther; 2016 Sep; 23(9):303-14. PubMed ID: 27492853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammalian cell transduction and internalization properties of lambda phages displaying the full-length adenoviral penton base or its central domain.
    Piersanti S; Cherubini G; Martina Y; Salone B; Avitabile D; Grosso F; Cundari E; Di Zenzo G; Saggio I
    J Mol Med (Berl); 2004 Jul; 82(7):467-76. PubMed ID: 15150649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective gene transfer to human melanomas via integrin-targeted adenoviral vectors.
    Nakamura T; Sato K; Hamada H
    Hum Gene Ther; 2002 Mar; 13(5):613-26. PubMed ID: 11916485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of penton RGD motifs affects the efficiency of both the internalization and the endosome escape of viral particles containing adenovirus serotype 5 or 35 fiber knobs.
    Shayakhmetov DM; Eberly AM; Li ZY; Lieber A
    J Virol; 2005 Jan; 79(2):1053-61. PubMed ID: 15613334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A genetically retargeted adenoviral vector enhances viral transduction in esophageal carcinoma cell lines and primary cultured esophageal resection specimens.
    Buskens CJ; Marsman WA; Wesseling JG; Offerhaus GJ; Yamamoto M; Curiel DT; Bosma PJ; van Lanschot JJ
    Ann Surg; 2003 Dec; 238(6):815-24; discussion 825-6. PubMed ID: 14631218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental treatment of ovarian cancers by adenovirus vectors combining receptor targeting and selective expression of tumor necrosis factor.
    Murugesan SR; Akiyama M; Einfeld DA; Wickham TJ; King CR
    Int J Oncol; 2007 Oct; 31(4):813-22. PubMed ID: 17786312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.